We are live on
!
Find out more
ED
Exane Derivatives Portfolio holdings
AUM
$174M
1-Year Est. Return
7.84%
This Fund
S&P 500
This Quarter
Est. Return
+2.15%
1 Year Est. Return
-7.84%
3 Year Est. Return
+42.72%
5 Year Est. Return
+56.28%
10 Year Est. Return
–
AUM
$466M
AUM Growth
+$23.6M
(+5.3%)
Cap. Flow
-$35.1M
Cap. Flow
% of AUM
-7.54%
Top 10 Holdings %
Top 10 Hldgs %
39.12%
Holding
698
New
128
Increased
157
Reduced
205
Closed
67
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
UBS Group
UBS
|
+$7.93M |
| 2 |
iShares MSCI Emerging Markets ETF
EEM
|
+$7.4M |
| 3 |
Stellantis
STLA
|
+$6.45M |
| 4 |
RAI
Reynolds American Inc
RAI
|
+$6.05M |
| 5 |
WIX.com
WIX
|
+$4.78M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
RSX
VanEck Russia ETF
RSX
|
+$15M |
| 2 |
iShares MSCI Taiwan ETF
EWT
|
+$11.5M |
| 3 |
Vale
VALE
|
+$9.09M |
| 4 |
United States Oil Fund
USO
|
+$7.39M |
| 5 |
iShares China Large-Cap ETF
FXI
|
+$7.31M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 12.82% |
| 2 | Consumer Discretionary | 7.26% |
| 3 | Technology | 6.74% |
| 4 | Consumer Staples | 5.01% |
| 5 | Materials | 4.73% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
226
RTX Corp
RTX
$289B
| $141K | 0.03% |
+1,840
| New | +$138K |
|
227
Motorola Solutions
MSI
$71.5B
| $140K | 0.03% |
1,613
+1,001
| +164% | +$84.9K |
|
228
Bath & Body Works
BBWI
$4.02B
| $139K | 0.03% |
3,200
-4,010
| -56% | -$164K |
|
229
Leggett & Platt
LEG
$1.37B
| $139K | 0.03% |
2,652
+2,650
| +132,500% | +$138K |
|
230
Direxion Daily 20+ Year Treasury Bear 3X ETF
TMV
$183M
| $139K | 0.03% |
2,842
-2,389
| -46% | -$123K |
|
|
IPG
231
DELISTED
Interpublic Group of Companies
IPG
| $139K | 0.03% |
5,634
+3,631
| +181% | +$88.7K |
|
232
HP
HPQ
$24.6B
| $136K | 0.03% |
7,800
+4,474
| +135% | +$82.1K |
|
233
Marathon Petroleum
MPC
$91.7B
| $135K | 0.03% |
2,589
+2,500
| +2,809% | +$129K |
|
234
BorgWarner
BWA
$13.2B
| $135K | 0.03% |
+3,615
| New | +$131K |
|
235
HealthEquity
HQY
$8.44B
| $132K | 0.03% |
+2,651
| New | +$124K |
|
236
Zions Bancorporation
ZION
$10.1B
| $132K | 0.03% |
+2,997
| New | +$123K |
|
237
NOV
NOV
$6.93B
| $131K | 0.03% |
3,985
+2,121
| +114% | +$73.2K |
|
238
Mondelez International
MDLZ
$80.5B
| $130K | 0.03% |
3,015
-879
| -23% | -$39.6K |
|
|
ETFC
239
DELISTED
E*Trade Financial Corporation
ETFC
| $130K | 0.03% |
+3,420
| New | +$121K |
|
|
BNY
240
Bank of New York Mellon
BNY
$106B
| $130K | 0.03% |
+2,542
| New | +$122K |
|
241
BlackBerry
BB
$4.95B
| $129K | 0.03% |
12,959
-15,408
| -54% | -$152K |
|
242
Wintrust Financial
WTFC
$10.8B
| $128K | 0.03% |
+1,673
| New | +$120K |
|
|
CXO
243
DELISTED
CONCHO RESOURCES INC.
CXO
| $126K | 0.03% |
1,038
+739
| +247% | +$93.4K |
|
244
Texas Capital Bancshares
TCBI
$4.29B
| $125K | 0.03% |
+1,613
| New | +$124K |
|
|
CMA
245
DELISTED
Comerica
CMA
| $125K | 0.03% |
+1,704
| New | +$120K |
|
246
CALL
AstraZeneca
AZN
$266B
| $124K | 0.03% |
122
+4
| +3% | +$261 |
|
|
247
PUT
AstraZeneca
AZN
$266B
| $124K | 0.03% |
+13
| New | +$849 |
|
|
OXLC
248
Oxford Lane Capital
OXLC
$876M
| $121K | 0.03% |
2,451
-25
| -1% | -$1.34K |
|
249
Bank OZK
OZK
$5.57B
| $119K | 0.03% |
+2,532
| New | +$120K |
|
|
SIVB
250
DELISTED
SVB Financial Group
SIVB
| $119K | 0.03% |
+675
| New | +$121K |
|
Similar funds
PC
TWMP
LPWM
ACM
HWIS
LWM
EW
GDWAM
Exane Derivatives's Q2 2017 Portfolio in Review
As of Q2 2017, Exane Derivatives held 698 positions worth $466M, up 5.3% from $442M the previous quarter. Its ten largest holdings account for 39% of the portfolio.
Exane Derivatives withdrew a net $35.1M in Q2 2017, closing 67 positions and reducing 205 holdings. Its most notable exit was Deutsche Bank Aktiengesellschaft, an estimated $6.91M position sold in full.
By sector, the portfolio is most concentrated in Financials at 13% of assets, down from 14% a quarter earlier, followed by Consumer Discretionary and Technology.
Against the trend, Exane Derivatives opened a new position in UBS Group worth $8.27M.
- Exane Derivatives's largest Q2 2017 buy was UBS Group: 487,870 shares worth $8.27M.
- Exane Derivatives added most to iShares MSCI Emerging Markets ETF in Q2 2017, an estimated $7.4M increase.
- Exane Derivatives's biggest Q2 2017 reduction was VanEck Russia ETF, cutting an estimated $15M.
- Exane Derivatives fully exited Deutsche Bank Aktiengesellschaft in Q2 2017, selling an estimated $6.91M.
- Exane Derivatives's ten largest holdings make up 39% of its $466M portfolio in Q2 2017.
- Exane Derivatives opened 128 new positions and closed 67 in Q2 2017.
- Exane Derivatives's portfolio value rose 5.3% quarter-over-quarter to $466M.
Based on Exane Derivatives's 13F filing for Q2 2017, filed 17 Jul 2017.